Quarterly report · Q1
7776.TEDINET S100TFKG
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34m | 2024-01-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥190m | 2023-01-01 → 2023-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥31m | 2023-01-01 → 2023-03-31 | Standalone | Net sales |
| Operating income | −¥233m | 2024-01-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥182m | 2023-01-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥231m | 2024-01-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥710m | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥229m | 2024-01-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥230m | 2024-01-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥847m | 2023-01-01 → 2023-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Profit loss |
| Total assets | ¥2.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2023-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥291m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥301m | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2023-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-7.24 | 2024-01-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-29.43 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.81 | 2023-01-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 86.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.9% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 32,172,719 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,459,019 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 27,659,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥55m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥387,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥387,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥164m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥34m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥34m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥13m |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥34m |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥34m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | −¥177m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥54m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥115m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥13m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | −¥128m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 298
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 31448000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 314480 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 10919 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 31459019 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 314480 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 100 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 2163292000 | JPY |
| Cash and deposits | CurrentQuarterInstant_NonConsolidatedMember | 2088523000 | JPY |
| Accounts receivable trade | Prior1YearInstant_NonConsolidatedMember | 51871000 | JPY |
| Accounts receivable trade | CurrentQuarterInstant_NonConsolidatedMember | 25212000 | JPY |
| Merchandise and finished goods | Prior1YearInstant_NonConsolidatedMember | 15398000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant_NonConsolidatedMember | 17047000 | JPY |
| Work in process | Prior1YearInstant_NonConsolidatedMember | 4289000 | JPY |
| Work in process | CurrentQuarterInstant_NonConsolidatedMember | 3861000 | JPY |
| Raw materials and supplies | Prior1YearInstant_NonConsolidatedMember | 26504000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant_NonConsolidatedMember | 24975000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 90454000 | JPY |
| Other ca | CurrentQuarterInstant_NonConsolidatedMember | 99733000 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 2351811000 | JPY |
| Current assets | CurrentQuarterInstant_NonConsolidatedMember | 2259354000 | JPY |
| Investments and other assets | Prior1YearInstant_NonConsolidatedMember | 113957000 | JPY |
| Investments and other assets | CurrentQuarterInstant_NonConsolidatedMember | 114501000 | JPY |
| Noncurrent assets | Prior1YearInstant_NonConsolidatedMember | 113957000 | JPY |
| Noncurrent assets | CurrentQuarterInstant_NonConsolidatedMember | 114501000 | JPY |
| Assets | Prior1YearInstant_NonConsolidatedMember | 2465768000 | JPY |
| Assets | CurrentQuarterInstant_NonConsolidatedMember | 2373855000 | JPY |
| Accounts payable trade | Prior1YearInstant_NonConsolidatedMember | 3778000 | JPY |
| Accounts payable trade | CurrentQuarterInstant_NonConsolidatedMember | 7866000 | JPY |
| Current portion of long term loans payable | Prior1YearInstant_NonConsolidatedMember | 7500000 | JPY |
| Current portion of long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 8125000 | JPY |
| Provision for bonuses | Prior1YearInstant_NonConsolidatedMember | 4064000 | JPY |
| Provision for bonuses | CurrentQuarterInstant_NonConsolidatedMember | 16343000 | JPY |
| Other cl | Prior1YearInstant_NonConsolidatedMember | 108225000 | JPY |
| Other cl | CurrentQuarterInstant_NonConsolidatedMember | 83316000 | JPY |
| Current liabilities | Prior1YearInstant_NonConsolidatedMember | 123569000 | JPY |
| Current liabilities | CurrentQuarterInstant_NonConsolidatedMember | 115652000 | JPY |
| Long term loans payable | Prior1YearInstant_NonConsolidatedMember | 143750000 | JPY |
| Long term loans payable | CurrentQuarterInstant_NonConsolidatedMember | 141250000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant_NonConsolidatedMember | 33728000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant_NonConsolidatedMember | 33751000 | JPY |
| Noncurrent liabilities | Prior1YearInstant_NonConsolidatedMember | 177478000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant_NonConsolidatedMember | 175001000 | JPY |
| Liabilities | Prior1YearInstant_NonConsolidatedMember | 301047000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |